Clinical Trials Logo
NCT number NCT00000349
Study type Interventional
Source National Institute on Drug Abuse (NIDA)
Contact
Status Active, not recruiting
Phase Phase 1

Clinical Trial Summary

The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol, to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol modifies the subjective as well as physiological effects of cocaine. Taken together, these relatively D-1 selective agents can help determine the extent to which DA-1 binding affects the reinforcing effects of stimulants.


Clinical Trial Description

n/a


Study Design

Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Completed NCT01526538 - Improving Learning-based Treatment of Cocaine Dependence With Medication Phase 2
 Completed NCT00877435 - Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial N/A
 Active, not recruiting NCT00430690 - Acoustic Startle Reduction In Cocaine Dependence N/A
 Completed NCT00217997 - Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals N/A
 Active, not recruiting NCT00094315 - Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 Phase 1
 Terminated NCT00142883 - The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 N/A
 Completed NCT00218348 - Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo Phase 2
 Active, not recruiting NCT00000311 - Combining Behavioral Treatment With Agonist Maintenance - 1 Phase 3
 Completed NCT00158132 - Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 Phase 2
 Completed NCT00142844 - Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 Phase 2
 Completed NCT00000294 - Effects of Carvedilol on Cocaine Use in Humans - 11 Phase 2
 Completed NCT00015054 - Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 Phase 2
 Completed NCT00000308 - Dextroamphetamine-Cocaine Behavioral Intervention - 5 Phase 2
 Completed NCT00000188 - Selegiline in Treatment of Cocaine Dependence - 2 Phase 2
 Terminated NCT00000276 - Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Phase 1
 Completed NCT00000282 - Pemoline for Cocaine Abuse - 7 Phase 2
 Completed NCT00000314 - M-CPP and Fenfluramine in Cocaine Addicts - 3 Phase 2
 Completed NCT00000277 - Mazindol for Cocaine Abuse - 2 Phase 2
 Completed NCT00000280 - Glutaminergic Agents for Cocaine Abuse - 5 Phase 1
 Completed NCT00000306 - Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 Phase 2